By Porter Anderson, Editor-in-Chief | @Porter_Anderson
‘Continued Expansion and Accomplishment’As the European Hematology Association holds its 2023 congress in Frankfurt—with a digital component continuing Wednesday and Thursday (June 14 and 15)—Wiley has announced from its offices in the United States and in The Hague that it’s opening a new partnership to publish the open-access journal HemaSphere on behalf of the association, a key get for the publisher in scholarly circles.
The European Hematology Association is the continent’s largest community of hematologists, with a reported membership of more than 5,000 based in 112 countries.
Wiley’s new partnership is to begin in January.
HemaSphere has a firm footing among society-based medical journals, sporting its journal impact factor (JIF) of 8.3 from 2021, per Clarivate’s ratings, as well as full indexing in PubMed Central and Scopus with a May 2022 CiteScore of 5.4.
Led by editor-in-chief Jan Cools of the VIB-KU Leuven Center for Cancer Biology in Belgium, HemaSphere‘s coverage is intended to support hematology patient care, research, and education internationally.
The journal is fully open-access. It publishes peer-reviewed original basic, translational, and clinical research articles as well as guidelines, review articles, perspectives, and editorials.
In a prepared statement issued to the news media Monday (June 12), Shawn Morton—Wiley’s senior editorial director for health sciences—is quoted, saying, “Wiley continues to prioritize open-access publishing and the European Hematology Association is a membership organization committed to promoting excellence in patient care through research, and education.
“Our partnership aims to combine our strengths and establish HemaSphere as the foremost open resource for hematologists worldwide.”
And speaking for the association, its managing director, Ignacio Quiles, says, “The new collaboration between EHA and Wiley is an exciting opportunity for HemaSphere.
“As a leading open-access journal for the hematology community, HemaSphere is a prominent publication in the field. With Wiley as our publishing partner, we anticipate continued expansion and accomplishment.
“We’re certain that its knowledge and experience will be advantageous to HemaSphere‘s exceptional editors and editorial board, enabling them to further elevate the journal and its impact in the field of hematology.”